Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline
Start Date
January 31, 2005
Primary Completion Date
September 30, 2011
Study Completion Date
September 30, 2012
Conditions
Malignant Melanoma
Interventions
BIOLOGICAL
GV1001
Trial Locations (1)
0424
Oslo University Hospital, Oslo
All Listed Sponsors
lead
Oslo University Hospital
OTHER
NCT01247623 - Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma | Biotech Hunter | Biotech Hunter